5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer

Autor(es)

Galbiatti, A. L. S. ^[1] ; Ruiz, M. T. ^[1] ; Chicote-Biselli, P. M. ^[1] ; Raposo, L. S. ^[2] ; Maniglia, J. V. ^[2] ; Pavarino-Bertelli, E. C. ^[1] ; Goloni-Bertollo, E. M. ^[1]

Afiliação do(s) autor(es)

^[1] Unidade Pesquisa Genet & Biol Mol, Sao Jose Do Rio Preto, SP - Brazil

^[2] Fac Med Sao Jose Rio Preto, Dept Otorrinolaringol & Cirurgia Cabeca & Pescoco, Sao Jose Do Rio Preto, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Brazilian Journal of Medical and Biological Research; v. 43, n. 5, p. 445-450, MAY 2010.
• Citações Web of Science: 15
• Assunto(s): Neoplasias de cabeça e pescoço Polimorfismo genético

Resumo

The functional effect of the A>G transition at position 2756 on the MTR gene (5-methyltetrahydrofolate-homocysteine methyltransferase), involved in folate metabolism, may be a risk factor for head and neck squamous cell carcinoma (HNSCC). The frequency of MTR A2756G (rs1805087) polymorphism was compared between HNSCC patients and individuals without history of neoplasias. The association of this polymorphism with clinical histopathological parameters was evaluated. A total of 705 individuals were included in the study. The polymerase chain reaction-restriction fragment length polymorphism technique was used to genotype the polymorphism. For statistical analysis, the chi-square test (univariate analysis) was used for comparisons between groups and multiple logistic regression (multivariate analysis) was used for interactions between the polymorphism and risk factors and clinical histopathological parameters. Using univariate analysis, the results did not show significant differences in allelic or genotypic distributions. Multivariable analysis showed that tobacco and alcohol consumption (P < 0.05), AG genotype (P = 0.019) and G allele (P = 0.028) may be predictors of the disease and a higher frequency of the G polymorphic allele was detected in men with HNSCC compared to male controls (P = 0.008). The analysis of polymorphism regarding clinical histopathological parameters did not show any association with the primary site, aggressiveness, lymph node involvement or extension of the tumor. In conclusion, our data provide evidence that supports an association between the polymorphism and the risk of HNSCC. (AU)

• Processo FAPESP: 10/05231-2 - 5-methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer.
• Beneficiário: Eny Maria Goloni Bertollo
• Modalidade de apoio: Auxílio à Pesquisa - Publicações científicas - Artigo
• Processo FAPESP: 04/14573-3 - Polimorfismos de nucleotideos unicos (snps) em pacientes com cancer de cabeca e pescoco.
• Beneficiário: Eny Maria Goloni Bertollo
• Modalidade de apoio: Auxílio à Pesquisa - Regular